Under the agreement, UMN Pharma and its subsidiary, UNIGEN, will use Catalent’s GPEx technology for producing a number of biosimilars. UMN Pharma said for product development including clinical
The collaboration will also be involved in evaluating the new therapeutics in proof-of-concept clinical trials. To implement the development, the companies will form a Therapeutic Innovation Group (TIG),
The Phentermine product lines include phentermine HCl tablets 37.5mg and phentermine HCl capsules 15mg and 30mg. The purchase orders will allow the company to obtain required amounts of
The solution also allows the research files to be automatically uploaded into the correct file, without human intervention. I-Batch eliminates the manual document sorting and uploading process by
The trial was designed to evaluate safety and also to provide proof-of-concept for the ability of the compound to inhibit excessive uterine contractility. During the study the healthy
The BZA/CE is an investigational therapy developed by Wyeth Pharmaceuticals to tackle symptoms such as vasomotor symptoms and vulvar and vaginal atrophy associated with menopause and for prevention
The CardioSCORE test is a patented diagnostic blood test designed to improve risk prediction of major cardiovascular events beyond traditional risk factor assessments, such as the Framingham Risk
The data has also reported positive clinical response activity in classical Hodgkin Lymphoma (HL) patients, who could be the target population for future studies. Sponsored by the Fondazione
Patients enrolled in open label multicenter study established constant improvement in lesions throughout the study and demonstrated 42% reduction in eight weeks. XBiotech president and CEO John Simard
The new facility will support increased workforce as the company moves ahead with five late-stage development programs to commercialize four drug candidates. The 56,412ft² facility forms part of
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.